Cerutti Andrea, Zan Hong, Kim Edmund C, Shah Shefali, Schattner Elaine J, Schaffer András, Casali Paolo
Division of Molecular Immunology, Department of Pathology, Weill Medical College of Cornell University, New York, New York 10021, USA.
J Immunol. 2002 Dec 1;169(11):6594-603. doi: 10.4049/jimmunol.169.11.6594.
Chronic lymphocytic leukemia (CLL) results from the expansion of malignant CD5(+) B cells that usually express IgD and IgM. These leukemic cells can give rise in vivo to clonally related IgG(+) or IgA(+) elements. The requirements and modalities of this process remain elusive. Here we show that leukemic B cells from 14 of 20 CLLs contain the hallmarks of ongoing Ig class switch DNA recombination (CSR), including extrachromosomal switch circular DNAs and circle transcripts generated by direct S micro -->Sgamma, S micro -->Salpha, and S micro -->Sepsilon as well as sequential Sgamma-->Salpha and Sgamma-->Sepsilon CSR. Similar CLL B cells express transcripts for activation-induced cytidine deaminase, a critical component of the CSR machinery, and contain germline I(H)-C(H) and mature V(H)DJ(H)-C(H) transcripts encoded by multiple Cgamma, Calpha, and Cepsilon genes. Ongoing CSR occurs in only a fraction of the CLL clone, as only small proportions of CD5(+)CD19(+) cells express surface IgG or IgA and lack IgM and IgD. In vivo class-switching CLL B cells down-regulate switch circles and circle transcripts in vitro unless exposed to exogenous CD40 ligand and IL-4. In addition, CLL B cells that do not class switch in vivo activate the CSR machinery and secrete IgG, IgA, or IgE upon in vitro exposure to CD40 ligand and IL-4. These findings indicate that in CLL at least some members of the malignant clone actively differentiate in vivo along a pathway that induces CSR. They also suggest that this process is elicited by external stimuli, including CD40 ligand and IL-4, provided by bystander immune cells.
慢性淋巴细胞白血病(CLL)源于恶性CD5(+) B细胞的扩增,这些细胞通常表达IgD和IgM。这些白血病细胞在体内可产生克隆相关的IgG(+)或IgA(+)成分。这一过程的要求和方式仍不清楚。在此,我们表明,20例CLL中有14例的白血病B细胞具有正在进行的Ig类别转换DNA重组(CSR)的特征,包括染色体外转换环状DNA以及由直接的Smicro→Sgamma、Smicro→Salpha和Smicro→Sepsilon以及连续的Sgamma→Salpha和Sgamma→Sepsilon CSR产生的环状转录本。类似的CLL B细胞表达激活诱导的胞苷脱氨酶的转录本,这是CSR机制的关键组成部分,并包含由多个Cgamma、Calpha和Cepsilon基因编码的种系I(H)-C(H)和成熟的V(H)DJ(H)-C(H)转录本。正在进行的CSR仅发生在CLL克隆的一部分中,因为只有小部分CD5(+)CD19(+)细胞表达表面IgG或IgA且缺乏IgM和IgD。体内发生类别转换的CLL B细胞在体外会下调转换环和环状转录本,除非暴露于外源性CD40配体和IL-4。此外,在体内未发生类别转换的CLL B细胞在体外暴露于CD40配体和IL-4时会激活CSR机制并分泌IgG、IgA或IgE。这些发现表明,在CLL中,至少一些恶性克隆成员在体内沿着诱导CSR的途径进行积极分化。它们还表明,这一过程是由旁观者免疫细胞提供的外部刺激(包括CD40配体和IL-4)引发的。